Neurexin 3 Antikörper (AA 30-110)
Kurzübersicht für Neurexin 3 Antikörper (AA 30-110) (ABIN7225956)
Target
Alle Neurexin 3 (NRXN3) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 30-110
-
Verwendungszweck
- Neurexin IIIβ Polyclonal Antibody
-
Spezifität
- Neurexin IIIβ Polyclonal Antibody detects endogenous levels of Neurexin IIIβ protein.
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
-
Immunogen
- Synthesized peptide derived from the N-terminal region of human Neurexin IIIbeta at AA range: 30-110
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:20000). Not yet tested in other applications.
-
Kommentare
-
Primary Antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- Neurexin 3 (NRXN3)
-
Andere Bezeichnung
- Neurexin IIIbeta
-
Hintergrund
- Rabbit Anti-Neurexin IIIβ Polyclonal Antibody,NRXN3, KIAA0743, Neurexin-3-beta, Neurexin III-beta,NRXN3 (neurexin 3) encodes a member of a family of proteins that function in the nervous system as receptors and cell adhesion molecules. Extensive alternative splicing and the use of alternative promoters results in multiple transcript variants and protein isoforms for this gene, but the full-length nature of many of these variants has not been determined. Transcripts that initiate from an upstream promoter encode alpha isoforms, which contain epidermal growth factor-like (EGF-like) sequences and laminin G domains. Transcripts initiating from the downstream promoter encode beta isoforms, which lack EGF-like sequences. Genetic variation at this locus has been associated with a range of behavioral phenotypes, including alcohol dependence and autism spectrum disorder.,Neurexin-3-beta
-
Molekulargewicht
- observerd band 70kDa
-
Gen-ID
- 9369
-
UniProt
- Q9HDB5
Target
-